Skip to main content

Ultramicrosize Griseofulvin

NDC 42794-014 · Sigmapharm Laboratories, LLC

Generic nameUltramicrosize Griseofulvin
Dosage formTABLET
RouteORAL
Active ingredient(s)GRISEOFULVIN
Strength250 mg/1
Pharmacologic classDecreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
Marketing categoryANDA

Packages

42794-014-08 — 30 TABLET in 1 BOTTLE (42794-014-08)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0115-1724 — Ultramicrosize Griseofulvin Tablets, 0115-1725 — Ultramicrosize Griseofulvin Tablets, 0472-0013 — Griseofulvin, 0713-0850 — Griseofulvin, 0781-5514 — Griseofulvin, 0781-5515 — Griseofulvin, 0781-5827 — Ultramicrosize Griseofulvin, 0781-5828 — Ultramicrosize Griseofulvin, 23155-863 — Griseofulvin, 23155-864 — Griseofulvin, 23155-865 — griseofulvin, 42794-012 — Griseofulvin, 42794-013 — Ultramicrosize Griseofulvin, 62135-494 — Griseofulvin, 62135-495 — Griseofulvin, 62135-496 — griseofulvin, 62135-501 — ULTRAMICROSIZE GRISEOFULVIN, 62135-968 — Griseofulvin (microsize), 69097-361 — grisofulvin, 73308-435 — ULTRAMICROSIZE GRISEOFULVIN

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels